Incidence of pathogens infections in a Romanian Intensive Care Unit and sensitivity to antibiotics. A prospective single center study

1. Sękowska A, Gospodarek E, Kusza K. The prevalence of infections and colonisation with Klebsiella pneumoniae strains isolated in ICU patients. Anaesthesiol Intensive Ther. 2014;46:280-283.10.5603/AIT.2014.0045Search in Google Scholar

2. Różańska A, Bulanda M. Demographic characteristics of patients and their assessment of selected hygienic practices of hospital personnel in the context of safety climate of hospitalization. Am J Infect Control. 2015;43:354-357.10.1016/j.ajic.2014.12.022Search in Google Scholar

3. Singh S, Goyal R, Ramesh GS, et al. Control of hospital acquired infections in the ICU: A service perspective. Med Journal Armed Forces India. 2015;71:28-32.10.1016/j.mjafi.2014.08.008Search in Google Scholar

4. Sevransky JE, Martin GS, Shanholtz C, et al. Mortality in sepsis versus non-sepsis induced acute lung injury. Crit Care. 2009;13:R150.10.1186/cc8048Search in Google Scholar

5. Coelho FR, Martins JO. Diagnostic methods in sepsis: the need of speed. Rev Assoc Med Bras. 2012;58:498-504.10.1590/S0104-42302012000400024Search in Google Scholar

6. Singh S, Chaturvedi R, Garg SM, Datta R, Kumar A. Incidence of healthcare associated infection in the surgical ICU of a tertiary care hospital. Med Journal Armed Forces India. 2013;69:124-129.10.1016/j.mjafi.2012.08.028Search in Google Scholar

7. Dereli N, Ozayar E, Degerli S, Sahin S, Koç F. Three-Year Evaluation of Nosocomial Infection Rates of the ICU. Rev Bras Anestesiol. 2013;63:73-84.10.1016/S0034-7094(13)70199-5Search in Google Scholar

8. Harwan WA, Abbassi MM, El-Attar MM, Farid SF. Pharmacoeconomic study of antibiotics used in the treatment of lower respiratory tract infections in ICU patients: A case study in an Egyptian hospital. Bull Fac Pharmacy. 2014;52:135-144.10.1016/j.bfopcu.2014.04.001Search in Google Scholar

9. Scherbaum M, Kösters K, Mürbeth RE, et al. Incidence, pathogens and resistance patterns of nosocomial infections at a rural hospital in Gabon. BMC Infect Dis. 2014;14:124.10.1186/1471-2334-14-124394398724592922Search in Google Scholar

10. Guggenbichler J, Assadian O, Kramer M. Incidence and clinical implication of nosocomial infections associated with implantable biomaterials - catheters , ventilator-associated pneumonia , urinary tract infections. GMS Krankenhhyg Interdiszip. 2011;6:1-19.Search in Google Scholar

11. McDonald CI, Fung YL, Shekar K, et al. The impact of acute lung injury, ECMO and transfusion on oxidative stress and plasma selenium levels in an ovine model. J Trace Elem Med Biol. 2015;30:4-10.10.1016/j.jtemb.2015.01.00425744503Search in Google Scholar

12. Mérens A, Delacour H, Plésiat P, Cavallo J-D, Jeannot K. Pseudomonas aeruginosa et résistance aux antibiotiques. Rev Francoph des Lab. 2011;2011:49-62.10.1016/S1773-035X(11)71102-9Search in Google Scholar

13. Mahafza T, Batarseh S, Bsoul N. Early vs. late tracheostomy for the ICU patients: Experience in a referral hospital. Saudi J Anaesth. 2012;6:152-154.10.4103/1658-354X.97029338525822754442Search in Google Scholar

14. Juayang AC, Jr DGM, Reyes GBDL, Acosido MAD, Gallega CT. Review on the Antimicrobial Resistance of Pathogens from Tracheal and Endotracheal Aspirates of Patients with Clinical Manifestations of Pneumonia in Bacolod City in 2013. International Journal of Bacteriology. 2015;2015.10.1155/2015/942509474548026904750Search in Google Scholar

15. Gupta A, Ampofo K, Rubenstein D, Saiman L. Extended spectrum beta lactamase-producing Klebsiella pneumoniae infections: a review of the literature. J Perinatol. 2003;23:439-443.10.1038/sj.jp.721097313679928Search in Google Scholar

16. Shigemoto N, Kayama S, Kuwahara R, et al. A novel metallo-β- lactamase, IMP-34, in Klebsiella isolates with decreased resistance to imipenem. Diagn Microbiol Infect Dis. 2013;76:119-121.10.1016/j.diagmicrobio.2013.02.03023541689Search in Google Scholar

17. Charrouf FO, Hamze M, Mallat H, Achkar M, Dabboussia F. Characterization of resistance genes in 68 ESBL-producing Klebsiella pneumonia in Lebanon. Médecine Mal Infect. 2014;44:535-538.10.1016/j.medmal.2014.10.00125453362Search in Google Scholar

18. Murray CK, Hospenthal DR. Acinetobacter infection in the ICU. Crit Care Clin. 2008;24:237-248.10.1016/j.ccc.2007.12.00518361943Search in Google Scholar

19. Vourli S, Frantzeskaki F, Meletiadis J, et al. Synergistic interactions between colistin and meropenem against extensively drug-resistant and pandrug-resistant Acinetobacter baumannii isolated from ICU patients. Int J Antimicrob Agents. 2015;45:670-671.10.1016/j.ijantimicag.2015.02.00525795317Search in Google Scholar

20. Dueñas Díez AI, Bratos Pérez MA, Eiros Bouza JM, et al. Susceptibility of the Acinetobacter calcoaceticus-A. baumannii complex to imipenem, meropenem, sulbactam and colistin. Int J Antimicrob Agents. 2004;23:487-493.10.1016/j.ijantimicag.2003.09.02615120728Search in Google Scholar

21. Lesho E, Wortmann G, Moran K, Craft D. Fatal Acinetobacter baumannii infection with discordant carbapenem susceptibility. Clin Infect Dis. 2005;41:758-759.10.1086/43262316080102Search in Google Scholar

22. Ikonomidis A, Pournaras S, Maniatis AN, Legakis NJ, Tsakris A. Discordance of meropenem versus imipenem activity against Acinetobacter baumannii. Int J Antimicrob Agents. 2015;28:376-377.10.1016/j.ijantimicag.2006.07.007Search in Google Scholar

23. Jaruratanasirikul S, Sriwiriyajan S, Punyo J. Comparison of the pharmacodynamics of meropenem in patients with ventilator-associated pneumonia following administration by 3-hour infusion or bolus injection. Antimicrob Agents Chemother. 2005;49:1337-1339.10.1128/AAC.49.4.1337-1339.2005Search in Google Scholar

24. Wood GC, Hanes SD, Croce M a, Fabian TC, Boucher B a. Comparison of ampicillin-sulbactam and imipenem-cilastatin for the treatment of acinetobacter ventilator-associated pneumonia. Clin Infect Dis. 2002;34:1425-1430.10.1086/340055Search in Google Scholar

25. Yang Q, Zhang H, Cheng J, et al. In vitro activity of flomoxef and comparators against Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis producing extended-spectrum β-lactamases in China. Int J Antimicrob Agents. 2015;45:485-490.10.1016/j.ijantimicag.2014.11.012Search in Google Scholar

26. Kanayama A, Kobayashi I, Shibuya K. Distribution and antimicrobial susceptibility profile of extended-spectrum β-lactamase-producing Proteus mirabilis strains recently isolated in Japan. Int J Antimicrob Agents. 2015;45:113-118.10.1016/j.ijantimicag.2014.06.005Search in Google Scholar

27. Dzutsev A, Trinchieri G. Proteus mirabilis: The Enemy Within. Immunity. 2015;42:602-604.10.1016/j.immuni.2015.04.004Search in Google Scholar

28. O’Hara CM, Brenner FW, Miller JM. Classification, identification, and clinical significance of Proteus, Providencia, and Morganella. Clin Microbiol Rev. 2000;13:534-546.10.1128/CMR.13.4.534Search in Google Scholar

29. Nijssen S, Florijn A, Bonten MJM, et al. Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates. Int J Antimicrob Agents. 2015;24:585-591.10.1016/j.ijantimicag.2004.08.008Search in Google Scholar

30. De Champs C, Bonnet R, Sirot D, Chanal C, Sirot J. Clinical relevance of Proteus mirabilis in hospital patients: a two year survey. J Antimicrob Chemother. 2000;45:537-539.10.1093/jac/45.4.537Search in Google Scholar

31. Stürenburg E, Mack D. Extended-spectrum β-lactamases: implications for the clinical microbiology laboratory, therapy, and infection control. J Infect. 2015;47:273-295. 10.1016/S0163-4453(03)00096-3Search in Google Scholar

32. Hofmann A, Sommer R, Hauck D, et al. Synthesis of mannoheptose derivatives and their evaluation as inhibitors of the lectin LecB from the opportunistic pathogen Pseudomonas aeruginosa. Carbohydr Res. 2015;412:34-42.10.1016/j.carres.2015.04.010Search in Google Scholar

33. Sahner JH, Empting M, Kamal A, et al. Exploring the chemical space of ureidothiophene-2-carboxylic acids as inhibitors of the quorum sensing enzyme PqsD from Pseudomonas aeruginosa. Eur J Med Chem. 2015;96:14-21.10.1016/j.ejmech.2015.04.007Search in Google Scholar

34. Potron A, Poirel L, Nordmann P. Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: Mechanisms and epidemiology. Int J Antimicrob Agents. 2015;45:568-585.10.1016/j.ijantimicag.2015.03.001Search in Google Scholar

35. Michalopoulos a. S, Tsiodras S, Rellos K, Mentzelopoulos S, Falagas ME. Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: The renaissance of an old antibiotic. Clin Microbiol Infect. 2005;11:115-121.10.1111/j.1469-0691.2004.01043.xSearch in Google Scholar

36. Frédéric G, Julien T, Benoit R, et al. Selective digestive decontamination and empirical antimicrobial therapy of late - Onset ventilator - Associated pneumonia in trauma patients. J Acute Dis. 2012;1:1-6.10.1016/S2221-6189(13)60001-3Search in Google Scholar

37. Cohen MJ, Block CS, Moses AE, Nir-Paz R. Exposure to ertapenem is possibly associated with Pseudomonas aeruginosa antibiotic resistance. Clin Microbiol Infect. 2014;20:O188-196.10.1111/1469-0691.12362Search in Google Scholar

38. Van der Wolf PJ, Rothkamp A, Junker K, de Neeling AJ. Staphylococcus aureus (MSSA) and MRSA (CC398) isolated from post-mortem samples from pigs. Vet Microbiol. 2012;158(1-2):136-141.10.1016/j.vetmic.2012.01.025Search in Google Scholar

39. Paul M, Zemer-Wassercug N, Talker O, et al. Are all beta-lactams similarly effective in the treatment of methicillin-sensitive Staphylococcus aureus bacteraemia? Clin Microbiol Infect. 2011;17:1581-1586.Search in Google Scholar

40. Patel H, Nguyen GC. S1103 Association of Methicillin-Resistant Staph Aureus (MRSA) with Higher Mortality Among Hospitalized IBD Patients. Gastroenterology. 2009;136:A - 189.10.1016/S0016-5085(09)60852-0Search in Google Scholar

41. Köck R, Winner K, Schaumburg F, et al. Admission prevalence and acquisition of nasal carriage of meticillin-resistant Staphylococcus aureus (MRSA) in German rehabilitation centres. J Hosp Infect. 2014;87:115-118.10.1016/j.jhin.2014.02.00724792577Search in Google Scholar

42. González-Domínguez M, Seral C, Sáenz Y, et al. Epidemiological features, resistance genes, and clones among community-onset methicillinresistant Staphylococcus aureus (CO-MRSA) isolates detected in northern Spain. Int J Med Microbiol. 2012;302:320-326.10.1016/j.ijmm.2012.10.00323177275Search in Google Scholar

43. Goodwin KD, McNay M, Cao Y, et al. A multi-beach study of Staphylococcus aureus, MRSA, and enterococci in seawater and beach sand. Water Res. 2012;46:4195-4207.10.1016/j.watres.2012.04.001Search in Google Scholar

44. Rao N, Bennett JE. Eradication of methicillin resistant Staph aureus (MRSA) with ciprofloxacin. Am J Infect Control. 1989;17:117.10.1016/0196-6553(89)90116-8Search in Google Scholar

45. Chang Y-Y, Chuang Y-C, Siu LK, et al. Clinical features of patients with carbapenem nonsusceptible Klebsiella pneumoniae and Escherichia coli in intensive care units: a nationwide multicenter study in Taiwan. J Microbiol Immunol Infect. 2015;48:219-225.10.1016/j.jmii.2014.05.01025074627Search in Google Scholar

46. Jana M, Misra AK. Synthesis of trisaccharide and a tetrasaccharide repeating unit corresponding to the O-antigen of Shiga toxin producing Escherichia coli O177. Tetrahedron. 2015;71:3960-3965.10.1016/j.tet.2015.04.042Search in Google Scholar

47. Magdy A, Elhadidy M, Abd Ellatif ME, et al. Enteropathogenic Escherichia coli (EPEC): Does it have a role in colorectal tumourigenesis? A Prospective Cohort Study. Int J Surg. 2015;18:169-173.10.1016/j.ijsu.2015.04.07725937151Search in Google Scholar

48. Perepelov A V, Wang Q, Senchenkova SN, et al. Structure and gene cluster of the O-antigen of Escherichia coli O140. Carbohydr Res. 2015;411:33-36.10.1016/j.carres.2015.04.00425965146Search in Google Scholar

49. Zdorovenko EL, Golomidova AK, Prokhorov NS, et al. Structure of the O-polysaccharide of Escherichia coli O87. Carbohydr Res. 2015;412:15-18.10.1016/j.carres.2015.04.01425988496Search in Google Scholar

50. Giakkoupi P, Tryfinopoulou K, Polemis M, et al. Circulation of a multiresistant, conjugative, IncA/C plasmid within the nosocomial Providencia stuartii population in the Athens area. Diagn Microbiol Infect Dis. 2015;82:62-64.10.1016/j.diagmicrobio.2015.02.00925752202Search in Google Scholar

51. Mahrouki S, Chihi H, Bourouis A, et al. Nosocomial dissemination of plasmids carrying blaTEM-24, blaDHA-1, aac(6’)-Ib-cr, and qnrA6 in Providencia spp. strains isolated from a Tunisian hospital. Diagn Microbiol Infect Dis. 2015;81:50-52.10.1016/j.diagmicrobio.2014.09.02125315769Search in Google Scholar

52. Ovchinnikova OG, Moryl M, Shashkov AS, Chizhov AO, et al. Structure of the O-polysaccharide of Providencia alcalifaciens O2 containing ascarylose and N-(L-alanyl)-D-glucosamine. Carbohydr Res. 2015;401:11-15.10.1016/j.carres.2014.10.01625464076Search in Google Scholar

53. Luzzaro F, Mezzatesta M, Mugnaioli C, et al. Trends in production of extended-spectrum - β-lactamases among enterobacteria of medical interest: Report of the second Italian nationwide survey. J Clin Microbiol. 2006;44:1659-1664. 10.1128/JCM.44.5.1659-1664.2006147920716672390Search in Google Scholar